Constructing confidence intervals for cost-effectiveness ratios: An evaluation of parametric and non-parametric techniques using Monte Carlo simulation

被引:1
|
作者
Briggs, AH
Mooney, CZ
Wonderling, DE
机构
[1] Univ Oxford, Hlth Econ Res Ctr, Oxford Inst Hlth Sci, Oxford OX1 2JD, England
[2] Univ Oxford, Nuffield Coll, Oxford OX1 2JD, England
[3] W Virginia Univ, Dept Polit Sci, Morgantown, WV 26506 USA
[4] London Sch Hyg & Trop Med, Hlth Promot Sci Unit, London, England
关键词
D O I
10.1002/(SICI)1097-0258(19991215)18:23<3245::AID-SIM314>3.0.CO;2-2
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The statistic of interest in most health economic evaluations is the incremental cost-effectiveness ratio. Since the variance of a ratio estimator is intractable, the health economics literature has suggested a number of alternative approaches to estimating confidence intervals for the cost-effectiveness ratio. In this paper, Monte Carlo simulation techniques are employed to address the question of which of the proposed methods is most appropriate. By repeatedly sampling from a known distribution and applying the different methods of confidence interval estimation, it is possible to calculate the coverage properties of each method to see if these correspond to the chosen confidence level. As the results of a single Monte Carlo experiment would be valid only for that particular set of circumstances, a series of experiments was conducted in order to examine the performance of the different methods under a variety of conditions relating to the sample size, the coefficient of variation of the numerator and denominator of the ratio, and the covariance between costs and effects in the underlying data. Response surface analysis was used to analyse the results and substantial differences between the different methods of confidence interval estimation were identified. The methods, both parametric and non-parametric, which assume a normal sampling distribution performed poorly, as did the approach based on simply combining the separate intervals on costs and effects. The choice of method for confidence interval estimation can lead to large differences in the estimated confidence limits for cost-effectiveness ratios. The importance of such differences is an empirical question and will depend to a large extent on the role of hypothesis testing in economic appraisal. However, where it is suspected that the sampling distribution is skewed normal approximation methods produce particularly poor results and should be avoided. Copyright (C) 1999 John Wiley & Sons, Ltd.
引用
收藏
页码:3245 / 3262
页数:18
相关论文
共 50 条
  • [1] The parametric bootstrap: Reconciling parametric and non parametric methods in the estimation of confidence intervals for incremental cost-effectiveness ratios?
    Lilliu, H
    VALUE IN HEALTH, 2003, 6 (06) : 610 - 610
  • [2] Non-parametric methods for estimating confidence intervals around the Incremental Cost-Effectiveness Ratio
    Petrinco, Michele
    Gregori, Dario
    Lazzarato, Fulvio
    Brunello, Franco
    Veltri, Andrea
    Berchialla, Paola
    Pagano, Eva
    EPIDEMIOLOGIA & PREVENZIONE, 2008, 32 (06): : 307 - 313
  • [3] On parametric confidence intervals for the cost-effectiveness ratio
    Gardiner, JC
    Huebner, M
    Jetton, J
    Bradley, CJ
    BIOMETRICAL JOURNAL, 2001, 43 (03) : 283 - 296
  • [4] Monte Carlo simulation of cost-effectiveness ratios
    Filho, JAF
    Calil, SJ
    PROCEEDINGS OF THE 22ND ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-4, 2000, 22 : 595 - 598
  • [5] Advantages of Monte Carlo Confidence Intervals for Incremental Cost-Effectiveness Ratios: A Comparison of Five Methods
    Dong, Nianbo
    Maynard, Rebecca A.
    Kelcey, Benjamin
    Spybrook, Jessaca
    Li, Wei
    Bowden, A. Brooks
    Pham, Dung
    JOURNAL OF RESEARCH ON EDUCATIONAL EFFECTIVENESS, 2024,
  • [6] Non-parametric confidence intervals for covariance and correlation
    Withers C.S.
    Nadarajah S.
    METRON, 2014, 72 (3) : 283 - 306
  • [7] Evaluation of a non-parametric modelling for meropenem in critically ill patients using Monte Carlo simulation
    Ana Isabel Idoate Grijalba
    Azucena Aldaz Pastor
    Pierre Marquet
    Jean-Baptiste Woillard
    European Journal of Clinical Pharmacology, 2019, 75 : 1405 - 1414
  • [8] A NON-PARAMETRIC INDICATOR FOR THE COST-EFFECTIVENESS OF TOXICITY TESTS
    BYRD, DM
    JOURNAL OF THE AMERICAN COLLEGE OF TOXICOLOGY, 1984, 3 (02): : 157 - 157
  • [9] Evaluation of a non-parametric modelling for meropenem in critically ill patients using Monte Carlo simulation
    Idoate Grijalba, Ana Isabel
    Aldaz Pastor, Azucena
    Marquet, Pierre
    Woillard, Jean-Baptiste
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 (10) : 1405 - 1414
  • [10] A Monte Carlo evaluation of non-parametric estimators of expected shortfall
    Mehlitz, Julia S.
    Auer, Benjamin R.
    JOURNAL OF RISK FINANCE, 2020, 21 (04) : 355 - 397